Garry Menzel

Garry Menzel

Director/Board Member at BLACK DIAMOND THERAPEUTICS, INC.

Net worth: 152 233 $ as of 30/10/2026

61 year
Health Technology
Consumer Services
Finance

Profile

Garry E.
Menzel
is an Independent Director at Black Diamond Therapeutics, Inc. since 2017.
Holds director roles at Epilepsy Therapy Project and Roslin Cell Therapies Ltd. (starting 2025).
Serves as Independent Non-Executive Director at Adaptimmune Therapeutics Plc since 2023.
Member of the National Board at Epilepsy Foundation since 2003.
Principal at Royal College of Art.
Formerly President, Chief Executive Officer & Director at TCR² Therapeutics, Inc. from 2016 to 2023.
Managing Director at Credit Suisse Group AG in 2008.
Managing Director at The Goldman Sachs Group, Inc. in 2004.
Director at Institute for Systems Biology.
Independent Director at Stoke Therapeutics, Inc. from 2020 to 2026.
Chief Financial Officer at DaVita, Inc. from 2013 to 2015.
Chief Operating Officer at Regulus Therapeutics, Inc. from 2012 to 2013.
Chief Strategy Officer at Axcella Health, Inc. from 2015 to 2016.
Research Assistant at Smithkline Beecham Plc from 2004 to 2008.
Consultant at Bain & Co., Inc. from 1994 to 2004.
Operating Partner at GHO Capital Partners LLP from 2024 to 2026.
Education includes an undergraduate degree from Imperial College London (1985), a doctorate from the University of Cambridge (1988), and an MBA from Stanford Graduate School of Business (1994).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
25/06/2026 76,664 ( 0.13% ) 136 462 $ 30/10/2026
10/04/2025 4,117,680 ( 0.26% ) 15 771 $ 30/10/2026
30/03/2026 0 ( -.--% ) - $ 30/10/2026

Garry Menzel active positions

CompaniesPositionStart
BLACK DIAMOND THERAPEUTICS, INC. Director/Board Member 28/02/2017
ADAPTIMMUNE THERAPEUTICS PLC Director/Board Member 31/05/2023
Director/Board Member -
Director/Board Member 31/05/2025
Corporate Officer/Principal 16/03/2010
Corporate Officer/Principal 31/12/2002

Former positions of Garry Menzel

CompaniesPositionEnd
STOKE THERAPEUTICS, INC. Director/Board Member 02/06/2026
Private Equity Investor 01/01/2026
TCR2 THERAPEUTICS INC. Chief Executive Officer 31/12/2022
░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Garry Menzel's experience

Education of Garry Menzel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

95

1st degree connections

20

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies20

Health Services

Health Technology

Finance

Finance

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology